Business News›News›ET TV›COVID Vaccine Trials: AIIMS gives a nod for human trial of Covaxin, received more than 1000 applications
COVID Vaccine Trials: AIIMS gives a nod for human trial of Covaxin, received more than 1000 applications
AIIMS Delhi has received an overwhelming response for COVID Human Trials Phase 1 participation. Over 1000 volunteers have sent a request for being part of trials. 100 volunteers to be given the vaccine in the first phase.
3views
Read more on